C. Elling

发表

Molecular mechanism of 7TM receptor activation--a global toggle switch model.

T. Schwartz, T. Frimurer, B. Holst, 2006, Annual review of pharmacology and toxicology.

Bioluminescence Resonance Energy Transfer as a Screening Assay: Focus on Partial and Inverse Agonism

C. Elling, L. Elster, A. Heding, 2007, Journal of biomolecular screening.

Metal Ion-mediated Agonism and Agonist Enhancement in Melanocortin MC1 and MC4 Receptors*

T. Schwartz, B. Holst, C. Elling, 2002, The Journal of Biological Chemistry.

Construction of covalently coupled, concatameric dimers of 7TM receptors

T. Schwartz, C. Elling, D. Scholl, 2009, Journal of receptor and signal transduction research.

Metal Ion Site Engineering Indicates a Global Toggle Switch Model for Seven-transmembrane Receptor Activation*

T. Schwartz, T. Frimurer, B. Holst, 2006, Journal of Biological Chemistry.

Characterization of glucagon-like peptide-1 receptor beta-arrestin 2 interaction: a high-affinity receptor phenotype.

T. Schwartz, C. Elling, Rasmus Jorgensen, 2005, Molecular endocrinology.

NOVEL METHOD FOR THE STUDY OF RECEPTOR Ca2+ SIGNALLING EXEMPLIFIED BY THE NK1 RECEPTOR

T. Schwartz, C. Elling, A. Heding, 2002, Journal of receptor and signal transduction research.

Molecular mechanism of activation and inhibition of 7TM peptide receptors

T. Schwartz, M. Rosenkilde, C. Elling, 1994 .

Leukemic spleen cells are more potent than bone marrow-derived cells in a transgenic mouse model of CML

A. Trumpp, C. Elling, M. Essers, 2012, Leukemia.

Ins(1,4,5)P3 3-kinase-A overexpression induces cytoskeletal reorganization via a kinase-independent mechanism.

C. Elling, G. Mayr, M. Nalaskowski, 2008, The Biochemical journal.

Beta-Arrestin2 as a Competitor for GRK2 Interaction with the GLP-1 Receptor upon Receptor Activation

C. Elling, Rasmus Jorgensen, A. Heding, 2011, Pharmacology.

Characterization of G-Protein Coupled Receptor Kinase Interaction with the Neurokinin-1 Receptor Using Bioluminescence Resonance Energy Transfer

T. Schwartz, C. Elling, Rasmus Jorgensen, 2008, Molecular Pharmacology.

Characterization of G-Protein Coupled Receptor Kinase Interaction with the NK-1 Receptor Using BRET

T. Schwartz, C. Elling, Rasmus Jorgensen, 2007 .

Oxyntomodulin Differentially Affects Glucagon-Like Peptide-1 Receptor β-Arrestin Recruitment and Signaling through Gα

T. Schwartz, C. Elling, Rasmus Jorgensen, 2007, Journal of Pharmacology and Experimental Therapeutics.

Oxyntomodulin differentially affects glucagon-like peptide-1 receptor beta-arrestin recruitment and signaling through Galpha(s).

T. Schwartz, C. Elling, Rasmus Jorgensen, 2007, The Journal of pharmacology and experimental therapeutics.

Low brain CB1 receptor occupancy by a second generation CB1 receptor antagonist TM38837 in comparison with rimonabant in nonhuman primates: A PET study

B. Gulyás, C. Halldin, K. Varnäs, 2014, Synapse.

The Cannabinoid CB1 Antagonist TM38837 With Limited Penetrance to the Brain Shows Reduced Fear-Promoting Effects in Mice

C. Elling, C. Wotjak, F. Drago, 2019, Front. Pharmacol..

A physicogenetic method to assign ligand-binding relationships between 7TM receptors.

Evi Kostenis, Thomas M Frimurer, Trond Ulven, 2005, Bioorganic & medicinal chemistry letters.

BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells.

D. Tenen, C. Elling, A. Wagers, 2010, Blood.

Role of the Spleen In CML: Lessons from an Inducible Transgenic Mouse Model.

C. Elling, S. Koschmieder, W. Berdel, 2010 .

Metal‐Ion Sites as Structural and Functional Probes of Helix–Helix Interactions in 7TM Receptors

T. Schwartz, C. Elling, S. Hjorth, 1997, Annals of the New York Academy of Sciences.

Conversion of agonist site to metal-ion chelator site in the beta(2)-adrenergic receptor.

T. Schwartz, B. Holst, C. Elling, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Construction of a High Affinity Zinc Switch in the -Opioid Receptor (*)

T. Schwartz, C. Elling, S. Hjorth, 1996, The Journal of Biological Chemistry.

Conversion of antagonist-binding site to metal-ion site in the tachykinin NK-1 receptor

T. Schwartz, C. Elling, S. M. Nielsen, 1995, Nature.

Split-receptors in the tachykinin neurokinin-1 system--mutational analysis of intracellular loop 3.

T. Schwartz, C. Elling, S. M. Nielsen, 1998, European journal of biochemistry.

Common Structural Basis for Constitutive Activity of the Ghrelin Receptor Family*

T. Schwartz, B. Holst, C. Elling, 2004, Journal of Biological Chemistry.

Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects.

J. V. van Gerven, C. Elling, M. D. de Kam, 2013, British journal of clinical pharmacology.

Partial agonism through a zinc-Ion switch constructed between transmembrane domains III and VII in the tachykinin NK(1) receptor.

T. Schwartz, B. Holst, C. Elling, 2000, Molecular pharmacology.

Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome induce growth factor independence and leukemia-like disease.

Philipp Erben, Christoph Walz, Carsten Müller-Tidow, 2011, Blood.

Long-acting lipidated analogue of human pancreatic polypeptide is slowly released into circulation.

T. Schwartz, B. Holst, C. Elling, 2011, Journal of medicinal chemistry.

Steric hindrance mutagenesis versus alanine scan in mapping of ligand binding sites in the tachykinin NK1 receptor.

T. Schwartz, B. Holst, C. Elling, 1998, Molecular pharmacology.

Engineering of metal-ion sites as distance constraints in structural and functional analysis of 7TM receptors.

T. Schwartz, C. Elling, S. Hjorth, 1997, Folding & design.

Disulfide bridge engineering in the tachykinin NK1 receptor.

T. Schwartz, C. Elling, U. Raffetseder, 2000, Biochemistry.

Integrative Analyses for Omics Data: A Bayesian Mixture Model to Assess the Concordance of ChIP-chip and ChIP-seq Measurements

Martin Dugas, Hans-Ulrich Klein, Katja Ickstadt, 2012, Journal of toxicology and environmental health. Part A.

Connectivity and orientation of the seven helical bundle in the tachykinin NK‐1 receptor probed by zinc site engineering.

T. Schwartz, C. Elling, C. E. Elling, 1996, The EMBO journal.

Opsin Oligomerization in a Heterologous Cell System

C. Elling, L. Drinovec, M. Vrecl, 2006, Journal of receptor and signal transduction research.